BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38589452)

  • 1. Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model.
    Viana PHL; Schvarcz CA; Danics LO; Besztercei B; Aloss K; Bokhari SMZ; Giunashvili N; Bócsi D; Koós Z; Benyó Z; Hamar P
    Sci Rep; 2024 Apr; 14(1):8241. PubMed ID: 38589452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaustion of Protective Heat Shock Response Induces Significant Tumor Damage by Apoptosis after Modulated Electro-Hyperthermia Treatment of Triple Negative Breast Cancer Isografts in Mice.
    Danics L; Schvarcz CA; Viana P; Vancsik T; Krenács T; Benyó Z; Kaucsár T; Hamar P
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Mouse Breast Cancer Isografts.
    Schvarcz CA; Danics L; Krenács T; Viana P; Béres R; Vancsik T; Nagy Á; Gyenesei A; Kun J; Fonović M; Vidmar R; Benyó Z; Kaucsár T; Hamar P
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the heat shock response induced by modulated electro-hyperthermia (mEHT) in cancer.
    Viana P; Hamar P
    Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189069. PubMed ID: 38176599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter.
    Yoon YJ; Kim JA; Shin KD; Shin DS; Han YM; Lee YJ; Lee JS; Kwon BM; Han DC
    J Biol Chem; 2011 Jan; 286(3):1737-47. PubMed ID: 21078672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing therapeutic efficacy in triple-negative breast cancer and melanoma: synergistic effects of modulated electro-hyperthermia (mEHT) with NSAIDs especially COX-2 inhibition in in vivo models.
    Giunashvili N; Thomas JM; Schvarcz CA; Viana PHL; Aloss K; Bokhari SMZ; Koós Z; Bócsi D; Major E; Balogh A; Benyó Z; Hamar P
    Mol Oncol; 2024 Apr; 18(4):1012-1030. PubMed ID: 38217262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
    Ishikawa C; Mori N
    Med Oncol; 2023 May; 40(6):172. PubMed ID: 37165174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia.
    Kuo IM; Lee JJ; Wang YS; Chiang HC; Huang CC; Hsieh PJ; Han W; Ke CH; Liao ATC; Lin CS
    BMC Cancer; 2020 Jun; 20(1):603. PubMed ID: 32600429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines.
    Forika G; Kiss E; Petovari G; Danko T; Gellert AB; Krenacs T
    Pathol Oncol Res; 2021; 27():1610048. PubMed ID: 34955688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro.
    Vancsik T; Forika G; Balogh A; Kiss E; Krenacs T
    Cancer Med; 2019 Aug; 8(9):4292-4303. PubMed ID: 31183995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters.
    Kim JA; Kim Y; Kwon BM; Han DC
    J Biol Chem; 2013 Oct; 288(40):28713-26. PubMed ID: 23983126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.
    Tsang YW; Huang CC; Yang KL; Chi MS; Chiang HC; Wang YS; Andocs G; Szasz A; Li WT; Chi KH
    BMC Cancer; 2015 Oct; 15():708. PubMed ID: 26472466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia.
    Yang KL; Huang CC; Chi MS; Chiang HC; Wang YS; Hsia CC; Andocs G; Wang HE; Chi KH
    Oncotarget; 2016 Dec; 7(51):84082-84092. PubMed ID: 27556507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
    Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
    Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-Mediated Inhibition of Potential Hypoxia-Related Angiogenic Repair in Modulated Electro-Hyperthermia (mEHT)-Treated Murine Triple-Negative Breast Cancer Model.
    Bokhari SMZ; Aloss K; Leroy Viana PH; Schvarcz CA; Besztercei B; Giunashvili N; Bócsi D; Koós Z; Balogh A; Benyó Z; Hamar P
    ACS Pharmacol Transl Sci; 2024 Feb; 7(2):456-466. PubMed ID: 38357275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
    Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
    Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia.
    Andocs G; Meggyeshazi N; Balogh L; Spisak S; Maros ME; Balla P; Kiszner G; Teleki I; Kovago C; Krenacs T
    Cell Stress Chaperones; 2015 Jan; 20(1):37-46. PubMed ID: 24973890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Heat Shock Factor 1 Enhances Repressive Molecular Mechanisms on the POMC Promoter.
    Ciato D; Li R; Monteserin Garcia JL; Papst L; D'Annunzio S; Hristov M; Tichomirowa MA; Belaya Z; Rozhinskaya L; Buchfelder M; Theodoropoulou M; Paez-Pereda M; Stalla GK
    Neuroendocrinology; 2019; 109(4):362-373. PubMed ID: 30995664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRIBB11 accelerates Mcl-1 degradation through an HSF1-independent, Mule-dependent pathway in A549 non-small cell lung cancer cells.
    Kang MJ; Yun HH; Lee JH
    Biochem Biophys Res Commun; 2017 Oct; 492(3):304-309. PubMed ID: 28859986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia-associated carboplatin resistance: differential role of p53, HSF1 and Hsp70 in hepatoma cells.
    Sharma A; Meena AS; Bhat MK
    Cancer Sci; 2010 May; 101(5):1186-93. PubMed ID: 20180806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.